PGG glucan companion diagnostic - HiberCell/Biodesix
Alternative Names: Imprime PGG companion diagnosticLatest Information Update: 15 Jan 2021
At a glance
- Originator Biodesix; HiberCell
- Class Diagnostic agents; Protein diagnostics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Breast cancer; Malignant melanoma
Most Recent Events
- 13 Jan 2021 Biodesix and HiberCell enter into a research collaboration to develop PGG glucan companion diagnostic for Malignant melanoma and Breast cancer
- 13 Jan 2021 Early research in Breast cancer (Diagnosis) in USA (unspecified route) prior to January 2021
- 13 Jan 2021 Early research in Malignant melanoma (Diagnosis) in USA (unspecified route) prior to January 2021